VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,158,000 | -90.8% | 57,500 | -53.8% | 0.05% | -88.4% |
| Q4 2015 | $12,639,000 | +51.0% | 124,336 | +165.0% | 0.40% | +64.9% |
| Q3 2015 | $8,370,000 | -88.8% | 46,925 | -86.1% | 0.24% | -83.9% |
| Q2 2015 | $74,831,000 | +43.7% | 336,851 | +28.5% | 1.52% | +42.5% |
| Q1 2015 | $52,069,000 | -10.9% | 262,160 | -35.8% | 1.07% | +7.4% |
| Q4 2014 | $58,420,000 | +114.6% | 408,216 | +97.7% | 1.00% | -8.5% |
| Q1 2014 | $27,219,000 | +139.9% | 206,467 | +113.7% | 1.09% | +75.5% |
| Q4 2013 | $11,344,000 | -22.1% | 96,623 | -30.8% | 0.62% | -34.3% |
| Q3 2013 | $14,567,000 | -4.9% | 139,623 | -21.6% | 0.94% | -19.8% |
| Q2 2013 | $15,324,000 | – | 178,023 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |